Physical activity to improve health: do not forget that the lungs benefit too Luis Puente-Maestu, William W. Stringer Eur Respir J, 51 (2) 1702468; 10.1183/13993003.02468-2017 | |
The scale of the problem of obstructive lung disease in Africa becomes clearer, but where are the solutions? Rupert Jones Eur Respir J, 51 (2) 1702562; 10.1183/13993003.02562-2017 | |
Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers Miguel Angel Martinez-García Eur Respir J, 51 (2) 1702497; 10.1183/13993003.02497-2017 | |
Effects of continuous positive airway pressure therapy on left ventricular diastolic function: a randomised, sham-controlled clinical trial Chi Young Shim, Darae Kim, Sungha Park, Chan Joo Lee, Hyung-Ju Cho, Jong-Won Ha, Yang-Je Cho, Geu-Ru Hong Eur Respir J, 51 (2) 1701774; 10.1183/13993003.01774-2017 | |
Does physical fitness enhance lung function in children and young adults? Robert J. Hancox, Finn Rasmussen Eur Respir J, 51 (2) 1701374; 10.1183/13993003.01374-2017 | |
Mindfulness-based cognitive therapy in COPD: a cluster randomised controlled trial Ingeborg Farver-Vestergaard, Mia S. O'Toole, Maja O'Connor, Anders Løkke, Elisabeth Bendstrup, Sharee A. Basdeo, Donal J. Cox, Pádraic J. Dunne, Kai Ruggeri, Frances Early, Robert Zachariae Eur Respir J, 51 (2) 1702082; 10.1183/13993003.02082-2017 | |
Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania Ng'weina Francis Magitta, Richard William Walker, Komalkirti Keshavkiran Apte, Meshack Denson Shimwela, Julius David Mwaiselage, Anna Alphonce Sanga, Anil Kumar Namdeo, Sapna Jitendra Madas, Sundeep Santosh Salvi Eur Respir J, 51 (2) 1700182; 10.1183/13993003.00182-2017 | |
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis David Araújo, Michal Shteinberg, Stefano Aliberti, Pieter C. Goeminne, Adam T. Hill, Thomas C. Fardon, Dusanka Obradovic, Glenda Stone, Marion Trautmann, Angela Davis, Katerina Dimakou, Eva Polverino, Anthony De Soyza, Melissa J. McDonnell, James D. Chalmers Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017 | |
Social deprivation and prognosis in Scottish patients with pulmonary arterial hypertension Katherine Pellino, Simon Kerridge, Colin Church, Andrew J. Peacock, Timothy Crowe, Geeshath Jayasekera, Martin K. Johnson, Alison M. MacKenzie Eur Respir J, 51 (2) 1700444; 10.1183/13993003.00444-2017 | |
Synergistic role of HSP90a and HSP90ß to promote myofibroblast persistence in lung fibrosis Pierre-Simon Bellaye, Chiko Shimbori, Toyoshi Yanagihara, David A. Carlson, Philip Hughes, Chandak Upagupta, Seidai Sato, Nolan Wheildon, Timothy Haystead, Kjetil Ask, Martin Kolb Eur Respir J, 51 (2) 1700386; 10.1183/13993003.00386-2017 | |
First trimester fetal size and prescribed asthma medication at 15 years of age Steve Turner, Shona Fielding, Graham Devereux Eur Respir J, 51 (2) 1701509; 10.1183/13993003.01509-2017 | |
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis Katherine O'Neill, Judy M. Bradley, Alastair Reid, Damian G. Downey, Jacqueline Rendall, John McCaughan, John E. Moore, Michael M. Tunney, J. Stuart Elborn Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017 | |
Role of a prolonged inpatient admission when evaluating children with problematic severe asthma Prasad Nagakumar, Nikki Gambir, Nina Sanghani, Pippa Hall, Angela Jamalzadeh, Frances Beresford, Sejal Saglani, Andrew Bush, Louise Fleming Eur Respir J, 51 (2) 1701061; 10.1183/13993003.01061-2017 | |
Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules Sukhwinder Singh Sohal Eur Respir J, 51 (2) 1702257; 10.1183/13993003.02257-2017 | |
“Global strategy for asthma management and prevention: GINA executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143–178.
Eur Respir J, 51 (2) 0751387; 10.1183/13993003.51387-2007 | |
ERJ February Podcast: Effectiveness versus efficacy
Eur Respir J, 51 (2) 18E5102; 10.1183/13993003.E5102-2018 | |
Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who suffer from chronic respiratory diseases Thomas Similowski Eur Respir J, 51 (2) 1800316; 10.1183/13993003.00316-2018 | |
On Don Quixote and pink puffers: multi-organ loss of tissue COPD Joan B. Soriano, Pierre-Régis Burgel Eur Respir J, 51 (2) 1702560; 10.1183/13993003.02560-2017 | |
Palliative care for people with COPD: effective but underused David M.G. Halpin Eur Respir J, 51 (2) 1702645; 10.1183/13993003.02645-2017 | |
Revising our approach to conducting therapeutic clinical research in COPD Gerard J. Criner Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 | |
Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension? Steven Hsu, Ryan J. Tedford Eur Respir J, 51 (2) 1702589; 10.1183/13993003.02589-2017 | |
Heat shock protein-90 toward theranostics: a breath of fresh air in idiopathic pulmonary fibrosis Philippe Bonniaud, Olivier Burgy, Carmen Garrido Eur Respir J, 51 (2) 1702612; 10.1183/13993003.02612-2017 | |
Putting the brake on accelerated lung function decline in asthma Dominic Shaw Eur Respir J, 51 (2) 1702630; 10.1183/13993003.02630-2017 | |
Adolescents and young adults: a neglected population group for tuberculosis surveillance Alberto L. García-Basteiro, H. Simon Schaaf, Roland Diel, Giovanni Battista Migliori Eur Respir J, 51 (2) 1800176; 10.1183/13993003.00176-2018 | |
The great breathlessness of cardiopulmonary diseases Robert Naeije, Vitalie Faoro Eur Respir J, 51 (2) 1702517; 10.1183/13993003.02517-2017 | |
Palatal prolapse as a signature of expiratory flow limitation and inspiratory palatal collapse in patients with obstructive sleep apnoea Ali Azarbarzin, Scott A. Sands, Melania Marques, Pedro R. Genta, Luigi Taranto-Montemurro, Ludovico Messineo, David P. White, Andrew Wellman Eur Respir J, 51 (2) 1701419; 10.1183/13993003.01419-2017 | |
Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype Bartolome R. Celli, Nicholas Locantore, Ruth Tal-Singer, John Riley, Bruce Miller, Jørgen Vestbo, Julie C. Yates, Edwin K. Silverman, Caroline A. Owen, Miguel Divo, Victor Pinto-Plata, Emiel F.M. Wouters, Rosa Faner, Alvar Agusti Eur Respir J, 51 (2) 1702146; 10.1183/13993003.02146-2017 | |
Low uptake of palliative care for COPD patients within primary care in the UK Chloe I. Bloom, Bhavan Slaich, Daniel R. Morales, Liam Smeeth, Patrick Stone, Jennifer K. Quint Eur Respir J, 51 (2) 1701879; 10.1183/13993003.01879-2017 | |
Analysis of airway pathology in COPD using a combination of computed tomography, micro-computed tomography and histology Naoya Tanabe, Dragos M. Vasilescu, Miranda Kirby, Harvey O. Coxson, Stijn E. Verleden, Bart M. Vanaudenaerde, Daisuke Kinose, Yasutaka Nakano, Peter D. Paré, James C. Hogg Eur Respir J, 51 (2) 1701245; 10.1183/13993003.01245-2017 | |
Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Ashley Woodcock, Isabelle Boucot, David A. Leather, Jodie Crawford, Susan Collier, Nawar Diar Bakerly, Emma Hilton, Jørgen Vestbo Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 | |
Macitentan in pulmonary hypertension due to left ventricular dysfunction Jean-Luc Vachiéry, Marion Delcroix, Hikmet Al-Hiti, Michela Efficace, Martin Hutyra, Gabriela Lack, Kelly Papadakis, Lewis J. Rubin Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017 | |
Sarcoidosis mortality in Sweden: a population-based cohort study Marios Rossides, Susanna Kullberg, Johan Askling, Anders Eklund, Johan Grunewald, Elizabeth V. Arkema Eur Respir J, 51 (2) 1701815; 10.1183/13993003.01815-2017 | |
Indoor bacteria and asthma in adults: a multicentre case–control study within ECRHS II Juha Pekkanen, Maria Valkonen, Martin Täubel, Christina Tischer, Hanna Leppänen, Päivi M. Kärkkäinen, Helena Rintala, Jan-Paul Zock, Lidia Casas, Nicole Probst-Hensch, Bertil Forsberg, Mathias Holm, Christer Janson, Isabelle Pin, Thorarinn Gislason, Debbie Jarvis, Joachim Heinrich, Anne Hyvärinen Eur Respir J, 51 (2) 1701241; 10.1183/13993003.01241-2017 | |
Predictors of accelerated decline in lung function in adult-onset asthma Hanneke Coumou, Guus A. Westerhof, Selma B. de Nijs, Aeilko H. Zwinderman, Elisabeth H. Bel Eur Respir J, 51 (2) 1701785; 10.1183/13993003.01785-2017 | |
Small airways dysfunction: the link between allergic rhinitis and allergic asthma Amaryllis Haccuria, Alain Van Muylem, Andrei Malinovschi, Vi Doan, Alain Michils Eur Respir J, 51 (2) 1701749; 10.1183/13993003.01749-2017 | |
Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial Hannele Pruikkonen, Terhi Tapiainen, Merja Kallio, Teija Dunder, Tytti Pokka, Matti Uhari, Marjo Renko Eur Respir J, 51 (2) 1701579; 10.1183/13993003.01579-2017 | |
Primary ciliary dyskinesia with normal ultrastructure: three-dimensional tomography detects absence of DNAH11 Amelia Shoemark, Thomas Burgoyne, Robert Kwan, Mellisa Dixon, Mitali P. Patel, Andrew V. Rogers, Alexandros Onoufriadis, Juliet Scully, Farheen Daudvohra, Thomas Cullup, Michael R. Loebinger, Robert Wilson, Eddie M.K. Chung, Andrew Bush, Hannah M. Mitchison, Claire Hogg Eur Respir J, 51 (2) 1701809; 10.1183/13993003.01809-2017 | |
The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial James C. Johnston, Mia L. van der Kop, Kirsten Smillie, Gina Ogilvie, Fawziah Marra, Mohsen Sadatsafavi, Kamila Romanowski, Matthew A. Budd, Jan Hajek, Victoria Cook, Richard T. Lester Eur Respir J, 51 (2) 1701488; 10.1183/13993003.01488-2017 | |
The incidence of tuberculosis among adolescents and young adults: a global estimate Kathryn J. Snow, Charalambos Sismanidis, Justin Denholm, Susan M. Sawyer, Stephen M. Graham Eur Respir J, 51 (2) 1702352; 10.1183/13993003.02352-2017 | |
E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells Lisa Miyashita, Reetika Suri, Emma Dearing, Ian Mudway, Rosamund E Dove, Daniel R. Neill, Richard Van Zyl-Smit, Aras Kadioglu, Jonathan Grigg Eur Respir J, 51 (2) 1701592; 10.1183/13993003.01592-2017 | |
Evolution of respiratory function in Duchenne muscular dystrophy from childhood to adulthood Antonella LoMauro, Marianna Romei, Sandra Gandossini, Riccardo Pascuzzo, Simone Vantini, Maria Grazia D'Angelo, Andrea Aliverti Eur Respir J, 51 (2) 1701418; 10.1183/13993003.01418-2017 | |
The role of air pollution and lung function in cognitive impairment Anke Hüls, Andrea Vierkötter, Dorothea Sugiri, Michael J. Abramson, Ulrich Ranft, Ursula Krämer, Tamara Schikowski Eur Respir J, 51 (2) 1701963; 10.1183/13993003.01963-2017 | |
Lung transplantation after allogeneic stem cell transplantation: a pan-European experience Mark Greer, Cristina Berastegui, Peter Jaksch, Christian Benden, John Aubert, Antoine Roux, Elodie Lhuillier, Sandrine Hirschi, Martine Reynaud-Gaubert, François Philit, Johanna Claustre, Pierre LePalud, Marc Stern, Christiane Knoop, Robin Vos, Erik Verschuuren, Andrew Fisher, Gerdt Riise, Lennart Hansson, Martin Iversen, Pekka Hämmäinen, Hans Wedel, Jacqueline Smits, Jens Gottlieb, Are M. Holm Eur Respir J, 51 (2) 1701330; 10.1183/13993003.01330-2017 | |
Immunotherapy: a new standard of care in thoracic malignancies? Adrien Costantini, Marta Grynovska, Francesca Lucibello, Jorge Moisés, Franck Pagès, Ming S. Tsao, Frances A. Shepherd, Hasna Bouchaab, Marina Garassino, Joachim G.J.V. Aerts, Julien Mazières, Michele Mondini, Thierry Berghmans, Anne-Pascale Meert, Jacques Cadranel Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017 | |
Ventilatory response to exercise in cardiopulmonary disease: the role of chemosensitivity and dead space Jason Weatherald, Caroline Sattler, Gilles Garcia, Pierantonio Laveneziana Eur Respir J, 51 (2) 1700860; 10.1183/13993003.00860-2017 | |
Tracheal replacement Harry Etienne, Dominique Fabre, Abel Gomez Caro, Frederic Kolb, Sacha Mussot, Olaf Mercier, Delphine Mitilian, Francois Stephan, Elie Fadel, Philippe Dartevelle Eur Respir J, 51 (2) 1702211; 10.1183/13993003.02211-2017 | |
Living with breathlessness: a systematic literature review and qualitative synthesis Ann Hutchinson, Natalie Barclay-Klingle, Kathleen Galvin, Miriam J. Johnson Eur Respir J, 51 (2) 1701477; 10.1183/13993003.01477-2017 | |
A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis Russell R. Kempker, M. Tobias Heinrichs, Ketino Nikolaishvili, Irina Sabulua, Nino Bablishvili, Shota Gogishvili, Zaza Avaliani, Brent P. Little, Adam Bernheim, Hartmut Derendorf, Henry M. Blumberg, Sergo Vashakidze, Charles A. Peloquin Eur Respir J, 51 (2) 1702166; 10.1183/13993003.02166-2017 | |
Detection of human cytomegalovirus in bronchoalveolar lavage of intensive care unit patients Andrea Vergara, Catia Cilloniz, Nestor Luque, Carolina Garcia-Vidal, Javier Tejero, Rafael Perelló, Carmen María Lucena, Antoni Torres, María Angeles Marcos Eur Respir J, 51 (2) 1701332; 10.1183/13993003.01332-2017 | |
Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study Luke E. Grzeskowiak, Lisa G. Smithers, Jessica A. Grieger, Tina Bianco-Miotto, Shalem Y. Leemaqz, Vicki L. Clifton, Lucilla Poston, Lesley M. McCowan, Louise C. Kenny, Jenny Myers, James J. Walker, Robert J Norman, Gus A. Dekker, Claire T. Roberts Eur Respir J, 51 (2) 1702035; 10.1183/13993003.02035-2017 | |
Dyspnoea modifies the recognition of fearful expressions by healthy humans Fabien Vinckier, Capucine Morélot-Panzini, Thomas Similowski Eur Respir J, 51 (2) 1702253; 10.1183/13993003.02253-2017 | |
Sex differences and factors influencing the duration of the QT interval in patients on anti-tuberculosis therapy Gerardo Alvarez-Uria, Manoranjan Midde Eur Respir J, 51 (2) 1702368; 10.1183/13993003.02368-2017 | |
Relapse-free cure from multidrug-resistant tuberculosis in Germany Jan Heyckendorf, Frank van Leth, Barbara Kalsdorf, Ioana D. Olaru, Gunar Günther, Helmut J.F. Salzer, Elena Terhalle, Thierry Rolling, Georg Glattki, Marius Müller, Maren Schuhmann, Korkut Avsar, Christoph Lange Eur Respir J, 51 (2) 1702122; 10.1183/13993003.02122-2017 | |
Variation in incidence trends of malignant pleural mesothelioma in Europe Mohammed Ahmed, Antoinette Flannery, Irfan Mujammil, David Breen Eur Respir J, 51 (2) 1702384; 10.1183/13993003.02384-2017 | |
Should gatifloxacin be included in the model list of essential medicines? Chen-Yuan Chiang, Arnaud Trébucq, Alberto Piubello, Hans L. Rieder, Armand Van Deun Eur Respir J, 51 (2) 1702329; 10.1183/13993003.02329-2017 | |
Tuberculosis re-treatment after exclusion of rifampicin resistance Chen-Yuan Chiang, Arnaud Trébucq Eur Respir J, 51 (2) 1702282; 10.1183/13993003.02282-2017 | |
Progress in the management of IPF-related acute exacerbations: a goal for patients, respirologists and intensivists François Vincent, Hilario Nunes, Stéphane Gaudry Eur Respir J, 51 (2) 1702419; 10.1183/13993003.02419-2017 | |
Progress in the management of IPF-related acute exacerbations: a goal for patients, respirologists and intensivists Ganesh Raghu Eur Respir J, 51 (2) 1800113; 10.1183/13993003.00113-2018 | |
“Pneumocystosis revealing immunodeficiency secondary to TERC mutation.” Raphael Borie, Caroline Kannengiesser, Flore Sicre de Fontbrune, David Boutboul, Laure Tabeze, Florence Brunet-Possenti, Elodie Lainey, Marie Pierre Debray, Aurélie Cazes and Bruno Crestani. Eur Respir J 2017; 50: 1701443.
Eur Respir J, 51 (2) 1751443; 10.1183/13993003.51443-2017 | |
“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444.
Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017 | |